AeroLeads people directory · profile

🚀 Sergei Pustylnikov, Ph.D. Email & Phone Number

CEO @ 100XBIO | Automating T-cell R&D for precise immune therapies at 100XBIO
Location: Stoneham, Massachusetts, United States 6 work roles 5 schools
1 work email found @ya.ru LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email p****@ya.ru
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
CEO @ 100XBIO | Automating T-cell R&D for precise immune therapies
Location
Stoneham, Massachusetts, United States

Who is 🚀 Sergei Pustylnikov, Ph.D.? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

🚀 Sergei Pustylnikov, Ph.D. is listed as CEO @ 100XBIO | Automating T-cell R&D for precise immune therapies at 100XBIO, based in Stoneham, Massachusetts, United States. AeroLeads shows a work email signal at ya.ru and a matched LinkedIn profile for 🚀 Sergei Pustylnikov, Ph.D..

🚀 Sergei Pustylnikov, Ph.D. previously worked as CEO at 100Xbio and Scientist 2, mRNA Vaccine Development at Greenlight Biosciences, Inc.. 🚀 Sergei Pustylnikov, Ph.D. holds Entrepreneurship Acceleration Program: Scaling Your Business from Wharton Executive Education.

Company email context

Email format at 100XBIO

This section adds company-level context without repeating 🚀 Sergei Pustylnikov, Ph.D.'s masked contact details.

*@ya.ru
68% confidence

AeroLeads found 1 current-domain work email signal for 🚀 Sergei Pustylnikov, Ph.D.. Compare company email patterns before reaching out.

Profile bio

About 🚀 Sergei Pustylnikov, Ph.D.

• Immunology leader focused on maximal impact in biotech R&D, 15+ years of experience.• T cell response, dendritic cells, innate immune response, cell-based assays, cancer immunology.• Prioritizing, adapting to change, growth, and networking. Ideating and leading complex projects.Passionate about: R&D, discoveries, new drugs, therapies, and therapeutic vaccines.My research profile: https://scholar.google.com/citations?user=gDC6zoEAAAAJ&hl=en

Listed skills include Molecular Biology, Cell Biology, Cell Culture, Biochemistry, and 40 others.

Current workplace

🚀 Sergei Pustylnikov, Ph.D.'s current company

Company context helps verify the profile and gives searchers a useful next step.

100XBIO
100Xbio
CEO @ 100XBIO | Automating T-cell R&D for precise immune therapies
AeroLeads page
6 roles

🚀 Sergei Pustylnikov, Ph.D. work experience

A career timeline built from the work history available for this profile.

Ceo

Current

Woburn, Massachusetts, Us

At 100XBIO we strive to deliver 100x more data on antigen specificity of the T cells in the limited sample volume (blood, tumor, lymph nodes), and as the downstream -- confirming the cells' phenotype and cytokine expression. All automated.Looking for (1) early investments, (2) R&D partners, and (3) early academia, biotech and pharma clients. We are raising $500K of pre-seed investment, and raised over $200K.***I have over 15 years of experience in building, expanding, and managing immunology labs. I self-led my Ph.D. and raised the scientific output of my institute to the next level, leaving after myself a well-equipped cell culture lab and mouse research facility. Selection of suitable equipment, suitable research methods, method development, and method optimization -- were always a pleasure to me.I have huge experience establishing scientific collaborations including international -- keeping in mind the best interest of both partnering parties in the long run. Teaching my colleagues and learning from them is an essential part of my job. Do they work in my lab, or overseas -- doesn't matter, we are all in the process of educating ourselves. I'm always thankful if you tell me where I'm wrong.My current task is to test the beautiful scientific and business hypotheses leading to better immuno-oncology tools, vaccines, & more. To execute this mission I need to get the company funded and the first projects started. I had a lot of failed scientific projects before and I have a strong feel for what's reliable. Step by step our technology starts working, and I sincerely hope it makes a global impact.

Jul 2023 - Present

Scientist 2, Mrna Vaccine Development

Medford, Ma, Us

Project and process management, execution• I led the project on the effects of transfected and lipid nanoparticles (LNP)-formulated mRNA in primary human immune cells/cell lines. I performed/managed 75 independent in vitro experiments, with the results guiding decision-making for product development. Methods: ELISA, IncuCyte, ELISpot, LEGENDplex and FACS.• For two preclinical programs, I performed 10+ T-cell response analysis experiments to provide the efficacy results for immunogenicity studies. Co-authored Animal Study Reports and a research paper with academic collaborators. Methods: intracellular cytokine staining, flow cytometry, double-color ELISpot, ELISpot.Team capabilities development, leadership• Mentored 2 Research Associates running 5 techniques. Trained them in experiment planning and data analysis, which resulted in their ability to run experiments from plan to the electronic lab notebook record. Both were promoted within a year due to exceptional performance.• Set up/optimized flow cytometry SOPs (14 colors), organized Luminex training, and helped set up the immunology laboratory (10 workspaces). Co-developed hypothesis-driven research plans for cross-functional teams. Gave multiple presentations to collaborating teams and higher management.

May 2021 - Jul 2023

Postdoctoral Fellow, Cancer Immunology

Pa, Us

Independent scientific work• Studied immunological differences between primary tumors and metastases to optimize cancer therapy. Automated quantification of immunohistochemical scans (>250), ran RNAseq gene expression data analysis.• Explored conditioning methods and complex FACS panels for dendritic cell-based cancer vaccines: improved viability & efficiency of cross-presentation and activation of CD8 T cells; MOA discovery studies.• Researched mtDNA's role in radiation therapy of tumors to discover new targets for immuno-oncology. Developed five mtDNA-free cell lines by rapid mtDNA-free cell cloning (fluorescent staining of <100 cells). Teamwork, lab operations, technical/scientific writing• Supported teamwork in syngeneic mouse tumor models: tissue processing, immune cells FACS, ELISPOT. • Responsible for lab orders and R&D product selection. Supervised learning of new methods by students.• Executed data collection and analysis; presented and discussed the findings that resulted in 3 conference abstracts and three published papers (1 first-authored), two under review/in preparation (1 first-authored).

Aug 2017 - Jan 2021

Researcher, Immunology Of Infection

Novosibirsk Tuberculosis Research Institute

• Organized the study of immunotherapeutic properties of existent drugs with the aim of potential repurposing for tuberculosis and HIV treatment (1.5M and 0.7M/year death tolls in 2019).• Started and maintained cell culture lab, managed orders, performed RT-qPCR, and ELISA. Mastered human PBMC isolation, macrophage, dendritic cell culture, nucleic acid isolation, cytokine measurement.• Designed in vivo efficacy studies of the immunological effects in mouse disease models.• Taught a course on scientific writing with 15-20 attendees that obtained a 4.7/5.0 “usefulness” rating.• Initiated 2 national and 2 international collaborations that resulted in 9 conference reports, 4 awards, and 5 published papers.Networking and learning:2015 -- Joint 4-months project with NooGen, a startup developing gene therapies based on a proprietary class of nucleic acid analogs2015 -- Part-time specialist/intern (1 month) in SYGMA Novosibirsk, providing analytical services for the development of biomedical startups

Nov 2011 - Feb 2017

Research Associate, Part-Time, Virology

Department of Retroviruses• Initiated a joint project and designed the experiments (with colleagues)• Performed in vitro experiments (with colleagues) and analyzed the results• Written the report and conference abstract; translated, edited and submitted a paper----------------------------Department of Zoonotic Disease and InfluenzaMay 2013 – December 2013 (8 months) | Koltsovo, RussiaResearch Associate, part-timeState Research Center of Virology and Biotechnology VECTOR• Initiated a joint project and designed the experiments (with colleagues), applied for a grant funding• Performed in vivo experiments (with colleagues) and analyzed the results• Written the report and conference abstract; presented a poster at ASM meeting in Boston

Nov 2014 - Dec 2016

Research Associate, Inflammation

Scientific Center For Clinical And Experimental Medicine

• Analyzed literature to develop the hypothesis; prepared experimental design• Ordered reagents and equipment; established new methods in the laboratory• Applied for grant funding; performed in vitro experiments; analyzed the data• Participated in conferences; drafted a review paper2010-2011 Chairperson of the council of young scientists:• Organized the seminars on professional development

Aug 2008 - Nov 2011
5 education records

🚀 Sergei Pustylnikov, Ph.D. education

Entrepreneurship Acceleration Program: Scaling Your Business

Wharton Executive Education

Doctor Of Philosophy (Ph.D.), Pathophysiology (Immunology)

Novosibirsk Tuberculosis Research Institute

Virology And Epidemiology

State Research Center Of Virology And Biotechnology "Vector"

Associate Of Science - As, Marketing And Management

Novosibirsk State University (Nsu)

Master’S Degree, Biology, Physiology

Novosibirsk State University (Nsu)
FAQ

Frequently asked questions about 🚀 Sergei Pustylnikov, Ph.D.

Quick answers generated from the profile data available on this page.

What company does 🚀 Sergei Pustylnikov, Ph.D. work for?

🚀 Sergei Pustylnikov, Ph.D. works for 100XBIO.

What is 🚀 Sergei Pustylnikov, Ph.D.'s role at 100XBIO?

🚀 Sergei Pustylnikov, Ph.D. is listed as CEO @ 100XBIO | Automating T-cell R&D for precise immune therapies at 100XBIO.

What is 🚀 Sergei Pustylnikov, Ph.D.'s email address?

AeroLeads has found 1 work email signal at @ya.ru for 🚀 Sergei Pustylnikov, Ph.D. at 100XBIO.

Where is 🚀 Sergei Pustylnikov, Ph.D. based?

🚀 Sergei Pustylnikov, Ph.D. is based in Stoneham, Massachusetts, United States while working with 100XBIO.

What companies has 🚀 Sergei Pustylnikov, Ph.D. worked for?

🚀 Sergei Pustylnikov, Ph.D. has worked for 100Xbio, Greenlight Biosciences, Inc., University Of Pennsylvania School Of Medicine, Novosibirsk Tuberculosis Research Institute, and State Research Center Of Virology And Biotechnology Vector.

How can I contact 🚀 Sergei Pustylnikov, Ph.D.?

You can use AeroLeads to view verified contact signals for 🚀 Sergei Pustylnikov, Ph.D. at 100XBIO, including work email, phone, and LinkedIn data when available.

What schools did 🚀 Sergei Pustylnikov, Ph.D. attend?

🚀 Sergei Pustylnikov, Ph.D. holds Entrepreneurship Acceleration Program: Scaling Your Business from Wharton Executive Education.

What skills is 🚀 Sergei Pustylnikov, Ph.D. known for?

🚀 Sergei Pustylnikov, Ph.D. is listed with skills including Molecular Biology, Cell Biology, Cell Culture, Biochemistry, In Vitro, Lifesciences, Genetics, and Microbiology.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.